Phone-based Intervention Under Nurse Guidance After Stroke 2

NCT ID: NCT04404166

Last Updated: 2026-01-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-23

Study Completion Date

2024-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of Phone-based Intervention under Nurse Guidance after Stroke II (PINGS-2) is to deploy a hybrid study design to firstly, demonstrate the efficacy of a theoretical-model-based, mHealth technology-centered, nurse-led, multi-level integrated approach to substantially improve longer term BP control among 500 recent stroke patients encountered at 10 hospitals in Ghana. Secondly, PINGS II seeks to develop an implementation strategy for routine integration and policy adoption of mhealth for post-stroke BP control in a LMIC setting. The investigators will leverage experience gained from the NIH Global Brain Disorders funded R21 pilot study (NS094033) to test efficacy of a refined, culturally-tailored, and potentially implementable intervention aimed at addressing the premier modifiable risk for stroke \& other key variables in an under-resourced system burdened by suboptimal care \& outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure Stroke Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PINGS 2

Participants received a 12-month, multicomponent, nurse-led intervention in addition to usual post-stroke care. The intervention included:

Home blood pressure monitoring at least weekly with nurse follow-up for threshold breaches.

Mobile phone medication reminders (daily alarms set on the participant's own device).

Weekly audio health education messages in local dialects emphasizing stroke risk factor control and medication adherence.

Nurse navigators provided case management, coordinated clinic visits as needed, and tracked blood pressure readings and adherence.

Group Type EXPERIMENTAL

PINGS 2

Intervention Type BEHAVIORAL

Home BP monitoring, medication reminders using phone alerts, and patient education on hypertension, cardiovascular risk reduction \& stroke

Standard of Care

Participants received standard secondary prevention after stroke according to local guidelines. This typically included periodic physician follow-up, antihypertensive therapy, antiplatelets, and statins prescribed at the clinician's discretion.

To maintain contact frequency similar to the intervention group, participants received neutral lifestyle text messages unrelated to hypertension or stroke prevention.

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Standard of Care (routine post-stroke management per guidelines)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PINGS 2

Home BP monitoring, medication reminders using phone alerts, and patient education on hypertension, cardiovascular risk reduction \& stroke

Intervention Type BEHAVIORAL

Standard of Care

Standard of Care (routine post-stroke management per guidelines)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18 years (stroke is commoner above this age cut-off)
* male or females (sex is a biologic variable of interest)
* recent stroke (within one month of symptom onset)- stroke may be ischemic or hemorrhagic based on brain imaging or diagnosed clinically using the locally validated version of the 8-item questionnaire for verifying stroke free status (8-QVSFS) when neuroimaging is not feasible
* uncontrolled HTN (SBP ≥ 140 mmHg at both the last clinical encounter post-stroke and the eligibility screening visit) - SBP is used as the selection variable since most African hypertensives \<60 years have systolic or combination systolic/ diastolic HTN and for most patients, controlling SBP also results in DBP control
* patients or family carers should own a basic mobile phone that can receive text/audio messages.

Exclusion Criteria

\- Any condition that would limit participation in follow up assessments, such as severe cognitive impairment/dementia (MMSE ≤24).
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Northern California Institute of Research and Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bruce Ovbiagele

Chief of Staff

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankaase Methodist Hospital

Aboaso, , Ghana

Site Status

Korle Bu Teaching Hospital

Accra, , Ghana

Site Status

Agogo Presbyterian Hospital

Agogo, , Ghana

Site Status

Cape Coast Teaching Hospital

Cape Coast, , Ghana

Site Status

Komfo Anokye Teaching Hospital

Kumasi, , Ghana

Site Status

Kumasi South Hospital

Kumasi, , Ghana

Site Status

Kwadaso SDA Hospital

Kumasi, , Ghana

Site Status

Kwame Nkrumah University of Science and Technology

Kumasi, , Ghana

Site Status

Manhyia Government Hospital

Kumasi, , Ghana

Site Status

Tafo Government Hospital

Kumasi, , Ghana

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ghana

References

Explore related publications, articles, or registry entries linked to this study.

Bockarie AS, Ayisi-Boateng NK, Nguah SB, Appiah LT, Fiattor T, Afriyie-Ansah S, MacCready E, Sam VA, Mensah NA, Tagge R, Agyenim-Boateng KG, Ampofo M, Laryea R, Gyamfi RA, Amuasi JH, Arthur AA, Duah C, Opare-Addo PA, Ovbiagele B, Sarfo FS, Akpalu A. The Significance of the WHO/ISH Absolute Cardiovascular Risk Prediction Scores among Recent Stroke Survivors in Ghana-Insights from the PINGS2 multicenter study. Res Sq [Preprint]. 2025 Mar 12:rs.3.rs-6175913. doi: 10.21203/rs.3.rs-6175913/v1.

Reference Type DERIVED
PMID: 40162227 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R01HL152188-05

Identifier Type: NIH

Identifier Source: secondary_id

View Link

20-30016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intermittent Oral Tube on Feeding Amount
NCT06328933 NOT_YET_RECRUITING NA
Autologous Stem Cell Therapy in Stroke
NCT02245698 WITHDRAWN PHASE1